These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 20505315)

  • 21. Interleukin-17A in lipid metabolism and atherosclerosis.
    Yu XH; Jiang N; Zheng XL; Cayabyab FS; Tang ZB; Tang CK
    Clin Chim Acta; 2014 Apr; 431():33-9. PubMed ID: 24508995
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulatory T-cell immunity and its relevance to atherosclerosis.
    Taleb S; Tedgui A; Mallat Z
    J Intern Med; 2008 May; 263(5):489-99. PubMed ID: 18410592
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synergy of IL-23 and Th17 cytokines: new light on inflammatory bowel disease.
    Shen W; Durum SK
    Neurochem Res; 2010 Jun; 35(6):940-6. PubMed ID: 19915978
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Two Faces of Interleukin-17A in Atherosclerosis.
    Akhavanpoor M; Akhavanpoor H; Gleissner CA; Wangler S; Doesch AO; Katus HA; Erbel C
    Curr Drug Targets; 2017; 18(7):863-873. PubMed ID: 28034277
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interleukin-27 receptor limits atherosclerosis in Ldlr-/- mice.
    Koltsova EK; Kim G; Lloyd KM; Saris CJ; von Vietinghoff S; Kronenberg M; Ley K
    Circ Res; 2012 Oct; 111(10):1274-85. PubMed ID: 22927332
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The tolerogenic role of IFN-γ.
    Rožman P; Švajger U
    Cytokine Growth Factor Rev; 2018 Jun; 41():40-53. PubMed ID: 29655565
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of T-helper cells in atherosclerosis.
    Lu X; Lu D; Narayan U; Kakkar VV
    Cardiovasc Hematol Agents Med Chem; 2011 Jan; 9(1):25-41. PubMed ID: 21054264
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interleukin-17 and systemic lupus erythematosus: current concepts.
    Nalbandian A; Crispín JC; Tsokos GC
    Clin Exp Immunol; 2009 Aug; 157(2):209-15. PubMed ID: 19604260
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of Th17 lymphocytes in the autoimmune and chronic inflammatory diseases.
    Murdaca G; Colombo BM; Puppo F
    Intern Emerg Med; 2011 Dec; 6(6):487-95. PubMed ID: 21258875
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interleukin-22: a likely target for treatment of autoimmune diseases.
    Yang X; Zheng SG
    Autoimmun Rev; 2014 Jun; 13(6):615-20. PubMed ID: 24418299
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Interleukin-23 / Interleukin-17 axis in intestinal inflammation.
    Maloy KJ
    J Intern Med; 2008 Jun; 263(6):584-90. PubMed ID: 18479257
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is atherosclerosis an autoimmune disease?
    Matsuura E; Atzeni F; Sarzi-Puttini P; Turiel M; Lopez LR; Nurmohamed MT
    BMC Med; 2014 Mar; 12():47. PubMed ID: 24642015
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of T-helper 17 (Th17) cells in patients with medulloblastoma.
    Zhou P; Sha H; Zhu J
    J Int Med Res; 2010; 38(2):611-9. PubMed ID: 20515574
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vascular endothelial growth factor is a key mediator in the development of T cell priming and its polarization to type 1 and type 17 T helper cells in the airways.
    Kim YS; Hong SW; Choi JP; Shin TS; Moon HG; Choi EJ; Jeon SG; Oh SY; Gho YS; Zhu Z; Kim YK
    J Immunol; 2009 Oct; 183(8):5113-20. PubMed ID: 19786548
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IL-6: regulator of Treg/Th17 balance.
    Kimura A; Kishimoto T
    Eur J Immunol; 2010 Jul; 40(7):1830-5. PubMed ID: 20583029
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Th17 cytokines and their emerging roles in inflammation and autoimmunity.
    Fouser LA; Wright JF; Dunussi-Joannopoulos K; Collins M
    Immunol Rev; 2008 Dec; 226():87-102. PubMed ID: 19161418
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immune-inflammatory responses in atherosclerosis: Role of an adaptive immunity mainly driven by T and B cells.
    Chistiakov DA; Orekhov AN; Bobryshev YV
    Immunobiology; 2016 Sep; 221(9):1014-33. PubMed ID: 27262513
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Innate and adaptive immunity in inflammatory bowel disease.
    Geremia A; Biancheri P; Allan P; Corazza GR; Di Sabatino A
    Autoimmun Rev; 2014 Jan; 13(1):3-10. PubMed ID: 23774107
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Amelioration of experimental autoimmune encephalomyelitis by curcumin treatment through inhibition of IL-17 production.
    Xie L; Li XK; Funeshima-Fuji N; Kimura H; Matsumoto Y; Isaka Y; Takahara S
    Int Immunopharmacol; 2009 May; 9(5):575-81. PubMed ID: 19539560
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human Th17 cells.
    Romagnani S
    Arthritis Res Ther; 2008; 10(2):206. PubMed ID: 18466633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.